Trial NCT02587962

View at ClinicalTrials.gov 
Org. Study IDs: BPT-201
Secondary IDs: MK3475 KEYNOTE KN163

Last trial update was posted on 2021-01-14

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Solid Tumors

Stopping Reasons

Based on a futility analysis, the data monitoring committee recommended to stop enrollment.

Limitations And Caveats

The dose escalation (Phase 1) part was analyzed per the protocol. Based on data from the interim analysis of the colorectal cancer cohort (dose expansion [Phase 2] part), the study was closed early due to futility on recommendation by the data monitoring committee (DMC).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID